Home » Authors » Anette Breindl

Articles by Anette Breindl

'Clinical Results Too Good To Be True,' Most Likely Are

Nov. 8, 2005

By Anette Breindl

Human Genome Haplotype Map Maps 'Genetic Neighborhoods'

Nov. 1, 2005

By Anette Breindl

Human Genome Haplotype Map Maps 'Genetic Neighborhoods'

Nov. 1, 2005

By Anette Breindl

Antibiotics Developers Report New Compounds, Mechanisms

Oct. 28, 2005

By Anette Breindl

Antibiotics Developers Report New Compounds, Mechanisms

Oct. 28, 2005

By Anette Breindl

Blocking Immune Signals To Brain Helps Sickness Healing

Oct. 24, 2005

By Anette Breindl

Blocking Immune Signals To Brain Helps Sickness Healing

Oct. 24, 2005

By Anette Breindl

'Act Locally' Easier Said Than Done In Chronic Pain Treatment

Oct. 20, 2005

By Anette Breindl

'Act Locally' Easier Said Than Done In Chronic Pain Treatment

Oct. 20, 2005

By Anette Breindl

Science Questions Remain As Animal Cloning Range Expands

Oct. 14, 2005

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 3, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
AI drives financings, approvals for APAC med-tech in 2024
BioWorld MedTech
AI pulled in major financings and approvals for Asia med-techs in 2024 as Asia Pacific countries played to individual strengths to maximize AI’s applications in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.